A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.

@article{Sigurgeirsson2017A5R,
  title={A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.},
  author={B{\'a}rður Sigurgeirsson and Thomas Anton Luger},
  journal={The British journal of dermatology},
  year={2017},
  volume={177 4},
  pages={1006}
}